Numerous studies have shown that promoter hypermethylation (e.g., of GATA4, RASSF1A, CDH1) is closely associated with tumor suppressor gene silencing, tumor progression, and poor prognosis (19). This evidence concerns the gene CDH1 and neoplasm.